Abstract
To investigate the association between urine exosome miR-223 and clinical markers with pathological severity of IgA nephropathy (IgAN) in order to offer a new perspective for the evaluation of IgAN patients. Western blotting and transmission electron microscopy were used to identify the exosomes collected and isolated from subjects' urine. qRT-PCR was then performed to determine the expression level of miR-223. Following that, the relationship between miR-223 expression, clinical markers, and the severity of pathology in IgAN patients was examined. (1) Urine can be used to isolate exosomes since its marker protein was visible by Western blotting, and its size and structure were observable using transmission electron microscopy. (2) Expression levels of miR-223 in urinary exosomes were much higher in IgAN patients than in healthy subjects, and these were also positively correlated with creatinine (Cr) (rho=0.396; p=0.006), blood urea nitrogen (BUN) (rho=0.371; p=0.011), 24-hour urinary microalbumin (24hU-mALB) (rho=0.341; p=0.036), mesangial cell proliferation (rho=0.359; p=0.014), glomerular segmental sclerosis (rho=0.417; p=0.004), cell/fibroblast crescents (rho=0.612; p=0.000), glomerulosclerosis, and renal interstitial fibrosis (rho=0.331; p=0.025). In urine exosomes, miR-223 might be considered a non-invasive biomarker for the assessment of IgAN disease progression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.